Yeah, but at least its coverage. Visibility is a good thing. Can't completely subscribe to the old, "the only bad press is NO press" like the media types do, but there is some truth in that, even for equities. This is still a supply and demand game, and more eyeballs means more potential buyers.
Good point, and I was not thinking about it that way. PT and buy out probably should be looked at differently, so guess we can give the analyst a little break with his LOW numbers. $50 and $800 mill valuation sound more fair to me, especially when we consider our brothers at THOR and HTWR. :-)
GLTA (Longs that is) :-)
$16 per share seems light. That only gives us a valuation of $256 million. Our solution is SUPERIOR to Circulite's. They should have given #$%$ least a $20 PT, to equal the $320 mill that HTWR committed/PAID, and personally, I believe SSH deserves a premium over what HTWR paid for Circulite. :-)
If interested in complete article, Googl title, "Sunshine Heart (SSH) on Watch Following Heartware's (HTWR) $320M Deal for Circulite"
"Summer Street analyst Mark Landy reiterated a Buy rating and $16 price target on Sunshine Heart (NASDAQ: SSH) Monday after Heartware (NASDAQ: HTWR) announced that it is buying Circulite for $320 million. $30 million upfront in cash and stock with the remaining $290 million in milestone payments for up to 8 to 10 years. "
To me it was a contrived short stunt. Four publications hit with the same store, different details, different people interviewed, on the same day? About a topic, that they really ALREADY new the answer too, but NOBODY included?? How does that happen??? All four writers, got the same idea at the same time, completed their stories, got them through editing and publishing, and they all hit the same day, and did not include the ANSWER, we already KNEW???? Seems like a contrived, and orchestrated short attack. :-( All for MONEY, who cares if we scare the XXXX out of patients.
Yes, received that too, and the food pairing document!!! Love the added dimension our chef, and all the new facility will be able to offer. They really have out done themselves! The new hospitality center and winery are gorgeous. WVVI will be a DESTINATION, that travelers don't want to miss. Also, should start to see more press as the articles are written about all the new additions
"Each of these wines was tasted blind, meaning I didn’t know who the producer was or how much it cost until my evaluation was complete. This ensured my decisions were based on the wine rather than the winery’s reputation."
"Some of these wines will be more difficult to find than others, but all should be obtainable. Ask for them at your favorite wine merchant or contact the winery directly."
Congratulations, Jim and WVVI team!!!!
"PICKING MY top wines of the region is like a high-wire act: dangerously fun.
Sorting through the 5,000 or so wines I evaluated in 2013 is a bit daunting, and the most difficult part of this list is deciding what to omit, because the Northwest produces so much world-class wine."
"Willamette Valley Vineyards 2010 Hannah pinot noir, Willamette Valley, $45: Owner Jim Bernau named this northern Willamette Valley vineyard for his daughter, and the resulting wines are subtle, elegant and complex."
In other words, UNFORTUNATELY/reality, it's not just about unmet medical needs, saving peoples lives, and being altruistic/holier than though "do gooders". NOPE, for too many in power, IT'S ABOUT THE MONEY. They don't care if they misrepresent, scare the XXXX out of a CHF patient, prevent someone from getting an implant, that they really need, take what is a difficult decision for many, and create/MAKE it a TRAUMATIC event, nah, it's about "ADVANTAGE", and the MONEY. GIANT :-(
Just an FYI, for those that are becoming aquatinted with medical/device/biotech investing. It may be the "holy" medical world, but GREED is in full force, AND the players still play, they just don't want you to know who's manipulating the game behind the curtain. :-(
"Among doctors who work with LVADs interviewed for this story, !!!!!! NONE !!!!!!!, including Starling, anticipate that they will stop offering them to patients. The benefits are too great, they argue. “LVADs improve survival, improve quality of life significantly so even with the residual pump thrombosis they were beating medical therapy by a large amount,” says Christopher O’Connor, chief of the division of cardiology at Duke and an expert in heart failure. “The reality is I don’t think this is going to change much,” says Alex Reyentovich, MD, an assistant professor of cardiology at the New York University School of Medicine. “For most of these patients this is not an elective procedure. Most of the patients we implant with these devices only have a year to live.”
"Among doctors who work with LVADs interviewed for this story, !!!!!! NONE !!!!!!, including Starling, anticipate that they will stop offering them to patients. The benefits are too great, they argue. “LVADs improve survival, improve quality of life significantly so even with the residual pump thrombosis they were beating medical therapy by a large amount,” says Christopher O’Connor, chief of the division of cardiology at Duke and an expert in heart failure. “The reality is I don’t think this is going to change much,” says Alex Reyentovich, MD, an assistant professor of cardiology at the New York University School of Medicine. “For most of these patients this is not an elective procedure. Most of the patients we implant with these devices only have a year to live.”
Somebody is acquiring as much as they can, at pretty high volume. Seems like there trying to acquire without push it over $5, as that would hit more radar and bring in more eyeballs. Come on $5 we need someone else to compete with our greedy/selfish buyer.
"Maison Louis Jadot is owned by the American Kopf family, which also owns the American import firm Kobrand. The Burgundy négociant produces approximately 100 to 130 separate Burgundy bottlings annually under the Louis Jadot label alone. In addition, the firm owns Domaine J.A. Ferret in Pouilly-Fuissé, Château des Jacques in Beaujolais' Morgon and Domaine du Duc de Magenta and Domaine Gagey in Burgundy. This is the company’s first venture outside of France."
Interesting math to ponder. :-)
"While the terms of the sale were not disclosed, Peter Bouman of Oregon Vineyard Property, who helped facilitate the sale, indicated that similar top Willamette hillside properties have sold recently for between $50,000 and $65,000 per acre."
Excerpt from the article.
“We were impressed by the quality of the wines we tasted from Resonance Vineyard,” Pierre-Henry Gagey, president of Maison Louis Jadot, told Wine Spectator. Its immediate neighbor is Gran Moraine, a 460-acre property recently purchased by Jackson Family Wines."